Cargando…

Impact of treatment time‐related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer

This study aimed to investigate the impact of treatment time‐related factors on outcomes and radiation proctitis in patients undergoing concurrent chemoradiotherapy (CCRT) for cervical cancer. From September 2001 to December 2012, 146 patients with stage IIB cervical squamous cell carcinoma treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Eng‐Yen, Lin, Hao, Wang, Chong‐Jong, Chanchien, Chan‐Chao, Ou, Yu‐Che
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055176/ https://www.ncbi.nlm.nih.gov/pubmed/27416796 http://dx.doi.org/10.1002/cam4.794

Ejemplares similares

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
por: Huang, Eng-Yen, et al.
Publicado: (2012)

Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial
por: Cheng, Yi‐Kan, et al.
Publicado: (2019)

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
por: Dreyfuss, Alexandra D., et al.
Publicado: (2021)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
por: Katsui, Kuniaki, et al.
Publicado: (2020)

Systematic review for non-surgical interventions for the management of late radiation proctitis
por: Denton, A S, et al.
Publicado: (2002)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
por: Jeong, Hyehyun, et al.
Publicado: (2021)

Management of radiation-induced proctitis
por: Porouhan, Pejman, et al.
Publicado: (2019)

Radiation Proctitis and Management Strategies
por: Dahiya, Dushyant Singh, et al.
Publicado: (2022)

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
por: Dai, Honghai, et al.
Publicado: (2019)

Radiation Proctitis: Current Strategies in Management
por: Do, Nhue L., et al.
Publicado: (2011)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020)

Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review
por: Lakomy, David S., et al.
Publicado: (2021)

A rat model for radiation-induced proctitis.
por: Kan, S., et al.
Publicado: (2000)

Chronic radiation proctitis: tricks to prevent and treat
por: Vanneste, Ben G. L., et al.
Publicado: (2015)

Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
por: Deng, Yuxia, et al.
Publicado: (2017)

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy
por: Gennigens, Christine, et al.
Publicado: (2020)

Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis
por: Wu, Szu-Yuan, et al.
Publicado: (2014)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
por: Hsieh, Jason Chia‐Hsun, et al.
Publicado: (2021)

Phlegmonous Proctitis: A Rare Entity of the Presentation of Proctitis
por: Kaewdech, Apichat, et al.
Publicado: (2018)

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
por: Mitra, Devarati, et al.
Publicado: (2019)

Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan
por: Pai, Ping Ching, et al.
Publicado: (2018)

Long‐term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial
por: Song, Tao, et al.
Publicado: (2016)

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
por: Che, Keying, et al.
Publicado: (2020)

Formalin Application for the Treatment of Radiation-Induced Hemorrhagic Proctitis
por: Lee, Sun-Il, et al.
Publicado: (2007)

Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
por: Maeda, Osamu, et al.
Publicado: (2016)

Development and validation of an interpretable radiomic nomogram for severe radiation proctitis prediction in postoperative cervical cancer patients
por: Wei, Chaoyi, et al.
Publicado: (2023)

High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer
por: Hou, Hailing, et al.
Publicado: (2017)

Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
por: Rojas‐Puentes, Leonardo, et al.
Publicado: (2016)

Severe Proctitis Caused by Chlamydia trachomatis Serovars D
por: Fukushima, Kazuaki, et al.
Publicado: (2016)

Proctitis following stereotactic body radiation therapy for prostate cancer
por: Joh, Daniel Y, et al.
Publicado: (2014)

Mesalazine suppository for the treatment of refractory ulcerative chronic radiation proctitis
por: Wu, Changliang, et al.
Publicado: (2018)

Altered Gut Microbiota Associated With Hemorrhage in Chronic Radiation Proctitis
por: Liu, Liangzhe, et al.
Publicado: (2021)

Radiation proctitis: predictors of mortality and inpatient outcomes in the United States
por: Dahiya, Dushyant S., et al.
Publicado: (2022)

Circulating microvesicles correlate with radiation proctitis complication after radiotherapy
por: Ribault, Alexandre, et al.
Publicado: (2023)

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
por: de Ruiter, Ben-Max, et al.
Publicado: (2022)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis
por: Ouboter, Laura F., et al.
Publicado: (2023)

Efficacy and complications of argon plasma coagulation for hemorrhagic chronic radiation proctitis
por: Zhong, Qing-Hua, et al.
Publicado: (2019)

Pravastatin Alleviates Radiation Proctitis by Regulating Thrombomodulin in Irradiated Endothelial Cells
por: Jang, Hyosun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g3dhu5oamkftn20osflcajtio7